Thermo Fisher Scientific Stock Performance
| TMO Stock | USD 521.66 0.00 0.00% |
The entity has a beta of 0.6, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Thermo Fisher's returns are expected to increase less than the market. However, during the bear market, the loss of holding Thermo Fisher is expected to be smaller as well. At this point, Thermo Fisher Scientific has a negative expected return of -0.25%. Please make sure to validate Thermo Fisher's total risk alpha, as well as the relationship between the accumulation distribution and relative strength index , to decide if Thermo Fisher Scientific performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Thermo Fisher Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return 3.02 | Five Day Return 2.69 | Year To Date Return (2.88) | Ten Year Return 308.74 | All Time Return 41.8 K |
Forward Dividend Yield 0.003 | Payout Ratio 0.0709 | Last Split Factor 3:2 | Forward Dividend Rate 1.56 | Dividend Date 2025-01-15 |
1 | Acquisition by Scott Sperling of tradable shares of Thermo Fisher subject to Rule 16b-3 | 09/27/2024 |
| Thermo Fisher dividend paid on 15th of October 2024 | 10/15/2024 |
2 | Disposition of 5850 shares by Marc Casper of Thermo Fisher at 210.68 subject to Rule 16b-3 | 11/01/2024 |
3 | Principal Financial Group Inc. Has 771.88 Million Stock Holdings in Thermo Fisher Scientific Inc. | 11/07/2024 |
4 | Gas Chromatography Market to Grow by USD 1.15 Billion , Driven by Expanding Applications, AI-Powered Report Highlights Market Trends - Technavio | 11/13/2024 |
5 | Top Analyst Reports for Thermo Fisher, NextEra Energy Lowes | 11/18/2024 |
6 | AMG National Trust Bank Sells 446 Shares of Thermo Fisher Scientific Inc. | 11/19/2024 |
7 | Transplant Therapeutics Consortium Receives FDA Acceptance of the Qualification Plan for iBox Scoring System | 11/20/2024 |
8 | Thermo Fisher Scientific Inc. Shares Acquired by L S Advisors Inc | 11/21/2024 |
9 | AlphaCore Capital LLC Invests 217,000 in Thermo Fisher Scientific Inc. | 11/22/2024 |
10 | United States Sterility Testing Market is Poised to Surpass valuation of US 1,198.13 Million By 2032 Pharmaceutical Products to Take a Center Stage in Revenue C... | 11/25/2024 |
| Begin Period Cash Flow | 8.5 B |
Thermo |
Thermo Fisher Relative Risk vs. Return Landscape
If you would invest 61,468 in Thermo Fisher Scientific on August 30, 2024 and sell it today you would lose (9,302) from holding Thermo Fisher Scientific or give up 15.13% of portfolio value over 90 days. Thermo Fisher Scientific is generating negative expected returns assuming volatility of 1.2271% on return distribution over 90 days investment horizon. In other words, 10% of stocks are less volatile than Thermo, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Thermo Fisher Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Thermo Fisher's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Thermo Fisher Scientific, and traders can use it to determine the average amount a Thermo Fisher's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2059
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TMO |
Estimated Market Risk
| 1.23 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Thermo Fisher is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Thermo Fisher by adding Thermo Fisher to a well-diversified portfolio.
Thermo Fisher Fundamentals Growth
Thermo Stock prices reflect investors' perceptions of the future prospects and financial health of Thermo Fisher, and Thermo Fisher fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Thermo Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0467 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 224.88 B | ||||
| Shares Outstanding | 382.5 M | ||||
| Price To Earning | 30.99 X | ||||
| Price To Book | 4.00 X | ||||
| Price To Sales | 4.63 X | ||||
| Revenue | 42.86 B | ||||
| Gross Profit | 19 B | ||||
| EBITDA | 6.86 B | ||||
| Net Income | 6 B | ||||
| Cash And Equivalents | 8.52 B | ||||
| Cash Per Share | 7.44 X | ||||
| Total Debt | 34.92 B | ||||
| Debt To Equity | 0.67 % | ||||
| Current Ratio | 1.74 X | ||||
| Book Value Per Share | 128.08 X | ||||
| Cash Flow From Operations | 8.41 B | ||||
| Earnings Per Share | 15.95 X | ||||
| Market Capitalization | 196.21 B | ||||
| Total Asset | 98.73 B | ||||
| Retained Earnings | 47.36 B | ||||
| Working Capital | 10.58 B | ||||
| Current Asset | 1.77 B | ||||
| Current Liabilities | 1.1 B | ||||
About Thermo Fisher Performance
By examining Thermo Fisher's fundamental ratios, stakeholders can obtain critical insights into Thermo Fisher's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Thermo Fisher is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 72.14 | 99.62 | |
| Return On Tangible Assets | 0.16 | 0.09 | |
| Return On Capital Employed | 0.08 | 0.05 | |
| Return On Assets | 0.06 | 0.03 | |
| Return On Equity | 0.13 | 0.07 |
Things to note about Thermo Fisher Scientific performance evaluation
Checking the ongoing alerts about Thermo Fisher for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Thermo Fisher Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Thermo Fisher generated a negative expected return over the last 90 days | |
| Over 91.0% of the company shares are owned by institutional investors | |
| On 15th of October 2024 Thermo Fisher paid $ 0.39 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: United States Sterility Testing Market is Poised to Surpass valuation of US 1,198.13 Million By 2032 Pharmaceutical Products to Take a Center Stage in Revenue Contribution Says Astute Analytica |
- Analyzing Thermo Fisher's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Thermo Fisher's stock is overvalued or undervalued compared to its peers.
- Examining Thermo Fisher's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Thermo Fisher's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Thermo Fisher's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Thermo Fisher's stock. These opinions can provide insight into Thermo Fisher's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Thermo Fisher Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Thermo Fisher. If investors know Thermo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Thermo Fisher listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.04) | Dividend Share 1.52 | Earnings Share 15.95 | Revenue Per Share 110.627 | Quarterly Revenue Growth 0.002 |
The market value of Thermo Fisher Scientific is measured differently than its book value, which is the value of Thermo that is recorded on the company's balance sheet. Investors also form their own opinion of Thermo Fisher's value that differs from its market value or its book value, called intrinsic value, which is Thermo Fisher's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Thermo Fisher's market value can be influenced by many factors that don't directly affect Thermo Fisher's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Thermo Fisher's value and its price as these two are different measures arrived at by different means. Investors typically determine if Thermo Fisher is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Thermo Fisher's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.